China BCT Pharmacy Group, Inc.
Other OTCTotal Valuation
China BCT Pharmacy Group, Inc. carries a market capitalization of 686,778.00, placing it among publicly traded companies globally. Its enterprise value stands at 3.44M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 686,778.00 |
| Enterprise Value | 3.44M |
Share Statistics
China BCT Pharmacy Group, Inc. currently has 38.15M shares outstanding.
| Shares Outstanding | 38.15M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
China BCT Pharmacy Group, Inc. trades at a trailing price-to-earnings ratio of 0.78. The price-to-sales ratio is 0.04, and the price-to-book ratio stands at 0.10.
| PE Ratio | 0.78 |
| PS Ratio | 0.04 |
| PB Ratio | 0.10 |
| P/TBV Ratio | 0.08 |
| P/FCF Ratio | -4.48 |
| P/OCF Ratio | -1.17 |
Enterprise Valuation
The EV/Sales ratio of 0.01 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 0.15 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.01 |
| EV / EBITDA | 0.14 |
| EV / EBIT | 0.15 |
| EV / FCF | N/A |
Financial Position
China BCT Pharmacy Group, Inc. maintains a current ratio of 2.54, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 11.78, indicating elevated leverage, while an interest coverage ratio of 20.25 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.54 |
| Quick Ratio | 2.21 |
| Debt / Equity | 11.78 |
| Debt / EBITDA | 0.64 |
| Interest Coverage | 20.25 |
Financial Efficiency
China BCT Pharmacy Group, Inc. posts a return on equity of 13.40 and a return on invested capital of 11.89.
| Return on Equity (ROE) | 13.40 |
| Return on Assets (ROA) | 6.64 |
| Return on Invested Capital (ROIC) | 11.89 |
| Return on Capital Employed (ROCE) | 16.32 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 10.57 |
Taxes
Over the trailing twelve months, China BCT Pharmacy Group, Inc. has paid 5.55M in income taxes, reflecting an effective tax rate of 24.89.
| Income Tax | 5.55M |
| Effective Tax Rate | 24.89 |
Stock Price Statistics
China BCT Pharmacy Group, Inc.'s stock has gained approximately 100% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 100% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, China BCT Pharmacy Group, Inc. generated 237.20M in revenue and converted that into 16.74M in net income, yielding earnings per share of 0.44. EBITDA reached 25.31M, while operating income came in at 23.28M.
| Revenue | 237.20M |
| Gross Profit | 43.42M |
| Operating Income | 23.28M |
| Pretax Income | 22.28M |
| Net Income | 16.74M |
| EBITDA | 25.31M |
| EBIT | 23.28M |
| Earnings Per Share (EPS) | 0.44 |
Balance Sheet
China BCT Pharmacy Group, Inc. holds 22.80M in cash and equivalents against 16.32M in total debt, resulting in a net debt position of -6.48M. Total book value stands at 100.53M, with working capital of 131.03M providing operational flexibility.
| Cash & Cash Equivalents | 22.80M |
| Total Debt | 16.32M |
| Net Debt | -6.48M |
| Equity (Book Value) | 100.53M |
| Book Value Per Share | 2.63 |
| Working Capital | 131.03M |
Cash Flow
China BCT Pharmacy Group, Inc. produced -8.47M in operating cash flow over the past twelve months. After subtracting -6.26M in capital expenditures, free cash flow totaled -14.73M - equivalent to -0.39 per share.
| Operating Cash Flow | -8.47M |
| Capital Expenditures | -6.26M |
| Free Cash Flow | -14.73M |
| FCF Per Share | -0.39 |
Margins
China BCT Pharmacy Group, Inc. operates with a gross margin of 18.30, reflecting its pricing power and cost economics. The operating margin of 9.81 and net profit margin of 7.06 provide insight into operational efficiency.
| Gross Margin | 18.30 |
| Operating Margin | 9.81 |
| Pretax Margin | 9.39 |
| Profit Margin | 7.06 |
| EBITDA Margin | 10.67 |
Dividends & Yields
The company's payout ratio of -30.96 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | -30.96 |
| Shareholder Yield | -61.47 |
| FCF Yield | -22.30 |
Scores
China BCT Pharmacy Group, Inc. posts an Altman Z-Score of 2.51, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.51 |